Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway

被引:67
作者
Peter, Angela K.
Crosbie, Rachelle H.
机构
[1] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90025 USA
[2] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
关键词
Akt; DMD; mdx; muscular dystrophy; hypertrophy; regeneration; IGF-1;
D O I
10.1016/j.yexcr.2006.04.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dystrophic muscle undergoes repeated cycles of degeneration/regeneration, characterized by the presence of hypertrophic fibers. in order to elucidate the signaling pathways that govern these events, we investigated Akt activation in normal and dystrophic muscle. Akt is activated in neonatal muscle and in actively dividing myoblasts, supporting a developmental role for Akt signaling. Akt activation was detected at very early, prenecrotic stages of disease pathogenesis, and maximal activation was observed during peak stages of muscle hypertrophy. Duchenne muscular dystrophy patients exhibit a similar pattern of Akt activation. Mice with sarcoglycan-deficient muscular dystrophy possess more severe muscle pathology and display elevated Akt signaling. However, the highest levels of Akt activation were found in dystrophin-utrophin-deficient muscle with very advanced dystrophy. We propose that Akt may serve as an early biomarker of disease and that Akt activation mediates hypertrophy in muscular dystrophy. Current investigations are focused on introducing constitutively active and dominant-negative Akt into prenecrotic mdx mice to determine how early modification of Akt activity influences disease pathogenesis. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:2580 / 2591
页数:12
相关论文
共 74 条
[41]   γ-Sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin [J].
Hack, AA ;
Ly, CT ;
Jiang, F ;
Clendenin, CJ ;
Sigrist, KS ;
Wollmann, RL ;
McNally, EM .
JOURNAL OF CELL BIOLOGY, 1998, 142 (05) :1279-1287
[42]   DYSTROPHIN - THE PROTEIN PRODUCT OF THE DUCHENNE MUSCULAR-DYSTROPHY LOCUS [J].
HOFFMAN, EP ;
BROWN, RH ;
KUNKEL, LM .
CELL, 1987, 51 (06) :919-928
[43]   DIFFERENTIATION OF FIBRE TYPES IN NORMAL AND DYSTROPHIC HAMSTER MUSCLE [J].
JOHNSON, M ;
PEARSE, AGE .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1971, 12 (04) :459-&
[44]   Intracellular signaling during skeletal muscle atrophy [J].
Kandarian, SC ;
Jackman, RW .
MUSCLE & NERVE, 2006, 33 (02) :155-165
[45]   Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); A novel nuclear target of Akt [J].
Koh, H ;
Jee, K ;
Lee, B ;
Kim, J ;
Kim, D ;
Yun, YH ;
Kim, JW ;
Choi, HS ;
Chung, J .
ONCOGENE, 1999, 18 (36) :5115-5119
[46]   Direct control of the Forkhead transcription factor AFX by protein kinase B [J].
Kops, GJPL ;
de Ruiter, ND ;
De Vries-Smits, AMM ;
Powell, DR ;
Bos, JL ;
Burgering, BMT .
NATURE, 1999, 398 (6728) :630-634
[47]   DUCHENNE BECKER MUSCULAR-DYSTROPHY - A SHORT OVERVIEW OF THE GENE, THE PROTEIN, AND CURRENT DIAGNOSTICS [J].
KUNKEL, LM ;
HOFFMAN, EP .
BRITISH MEDICAL BULLETIN, 1989, 45 (03) :630-643
[48]   Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells [J].
Langenbach, KJ ;
Rando, TA .
MUSCLE & NERVE, 2002, 26 (05) :644-653
[49]   rAAV vector-mediated sarcoglycan gene transfer in a hamster model for limb girdle muscular dystrophy [J].
Li, J ;
Dressman, D ;
Tsao, YP ;
Sakamoto, A ;
Hoffman, EP ;
Xiao, X .
GENE THERAPY, 1999, 6 (01) :74-82
[50]   The sarcoglycan complex in limb-girdle muscular dystrophy [J].
Lim, LE ;
Campbell, KP .
CURRENT OPINION IN NEUROLOGY, 1998, 11 (05) :443-452